Clinical manifestations of panniculitis: difficulties of diagnostics


DOI: https://dx.doi.org/10.18565/therapy.2022.2.57-64

Egorova O.N., Tarasova G.M., Lila A.M.

V.A. Nasonova Research Institute of Rheumatology, Moscow
Abstract. Article discusses the clinical and diagnostic difficulties of verification of variants of panniculitis. Successful diagnostics of the disease depends on a carefully collected anamnesis containing information about previous diseases, taken medicaments, underlying pathology, as well as an adequate assessment of clinical symptoms, laboratory parameters and identification of typical morphological changes. Three clinical observations of panniculites with main characteristic features of the course of the disease are presented.
Keywords: diagnostics of panniculitis, lipodermatosclerosis, Lofgren’s syndrome, panniculitis, erythema nodosum
Read entire article

Literature


  1. Owen E.D., Logan R., May K., Kalavala M. Panniculitis with an unusual diagnosis. Clin Exp Dermatol. 2020; 45(2): 215–17. https://dx.doi.org/10.1111/ced.13912.

  2. Morita T.C.A.B., Tres G.F.S, García M.S.C. et al. Panniculitides of particular interest to the rheumatologist. Adv Rheumatol. 2019; 59(1): 35. https://dx.doi.org/10.1186/s42358-019-0077-5.

  3. Nosewicz J., Hyde J., McGrath M. et al. Infectious panniculitis: An inpatient cohort. Int J Dermatol. 2021. https://dx.doi.org/10.1111/ijd.16004. Online ahead of print.

  4. Wick M.R. Panniculitis: А summary. Semin Diagn Pathol. 2017; 34(3): 261–72. https://dx.doi.org/10.1053/j.semdp.2016.12.004.

  5. Caputo V., Rongioletti F. Panniculitis in the setting of dermato/rheumatologic diseases. G Ital Dermatol Venereol. 2018; 153(2): 194–207. https://dx.doi.org/10.23736/S0392-0488.17.05845-X.

  6. Requena L., Yus E.S. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001; 45(2): 163–83; quiz 184–86. https://dx.doi.org/10.1067/mjd.2001.114736.

  7. Requena L., Yus E.S. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001; 45 (3): 325–61; quiz 362–64. https://dx.doi.org/10.1067/mjd.2001.114735.

  8. Егорова О.Н., Белов Б.С. Панникулиты в практике дерматовенеролога и интерниста. Consilium Medicum. 2020; 7: 78–83. [Egorova O.N., Belov B.S. Panniculitis in the practice of an internist and a dermatologist (a lecture). Consilium Medicum. 2020; 7: 78–83 (In Russ.)]. https://dx.doi.org/10.26442/20751753.2020.7.200288.

  9. Velter C., Lipsker D. Cutaneous panniculitis. Rev Med Interne. 2016; 37(11): 743–50. https://dx.doi.org/10.1016/j.revmed.2016.05.008.

  10. Раденска-Лоповок С.Г., Егорова О.Н., Белов Б.С. с соавт. Идиопатический лобулярный панникулит: клинико-морфологические корреляции. Архив патологии. 2019; 3: 37–44. [Radenska-Lopovok S.G., Egorova O.N., Belov B.B. et al. Idiopathic lobular panniculitis: clinical and morphological correlations (in Russian only). Arkhiv patologii = Archive of Pathology. 2019; 3: 37–44 (In Russ.)]. https://dx.doi.org/10.17116/patol20198103137.

  11. Leung A.K.C., Leong K.F., Lam J.M. Erythema nodosum. World J Pediatr. 2018; 14(6): 548–54. https://dx.doi.org/10.1007/s12519-018-0191-1.

  12. Kuriyama Y., Shimizu A., Oka H. et al. Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries. J Dermatol. 2021; 48(10): 1588–92. https://dx.doi.org/10.1111/1346-8138.16071.

  13. van Herwaarden N., van den Elsen G.A.H., de Jong I.C.A. et al. Topical NSAIDs: Ineffective or undervalued? Ned Tijdschr Geneeskd. 2021; 165: D5317.

  14. Caplan А., Rosenbach М., Imadojemu S. Cutaneous sarcoidosis. Semin Respir Crit Care Med. 2020; 41(5): 689–99. https://dx.doi.org/10.1055/s-0040-1713130.

  15. Vieira M.C., Tosta P.G., Nicole F.M. et al. Chronic inflammatory arthropathy preceding acute systemic manifestations of sarcoidosis: a possible overlap of idiopathic juvenile arthritis and sarcoidosis. Case Rep Rheumatol. 2019; 2019: 6483245. https://dx.doi.org/10.1155/ 2019/6483245.

  16. Клинические рекомендации (проект). Саркоидоз. ID: КР1. Российское респираторное общество, Общероссийское педиатрическое респираторное общество, Российское научное медицинское общество терапевтов. 2019. Доступ: https://spulmo.ru/download/2020_klin_rek_sarkoidoz_final.pdf (дата обращения – 11.02.2022). [Clinical guidelines (a project). Sarcoidosis. ID: КР1. Russian Respiratory Society, All-Russian Pediatric Respiratory Society, Russian Scientific Medical Society of Internal Medicine. 2019. URL: https://spulmo.ru/download/2020_klin_rek_sarkoidoz_final.pdf (date of access – 11.02.2022) (In Russ.)].

  17. Егорова О.Н., Белов Б.С., Романова К.Г. Клиническая манифестация поражения суставов при синдроме Лефгрена. Современная ревматология. 2020; 2: 35–40. [Egorova O.N., Belov B.S., Romanova K.G. Clinical symptoms of joint damage in Lofgren’s syndrome. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2020; 2: 35–40 (In Russ.)]. https://dx.doi.org/10.14412/1996-7012-2020-2-35-40.

  18. Gerke A., Hunninghake G. The immunology of sarcoidosis. Clin Chest Med. 2008; 29(3): 379–90, vii. https://dx.doi.org/10.1016/j.ccm.2008.03.014.

  19. Bargagli E., Mazzi A., Rottoli P. Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clin Chest Med. 2008; 29(3): 445–58, viii. https://dx.doi.org/10.1016/j.ccm.2008.03.004.

  20. Ziora D., Jastrzębski D., Adamek M. et al. Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis. BMC Pulm Med. 2015; 15: 113. https://dx.doi.org/10.1186/s12890-015-0110-3.

  21. Huang Y., Lu C.Z., Wang C.C. et al. Establishment and identification of a C57B/6 mouse sarcoidosis. Zhonghua Jie He He Hu Xi Za Zhi. 2013; 36(8): 587–91.

  22. Prasse A., Georges C.G., Biller H. et al. Jr. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol. 2000; 122(2): 241–48. https://dx.doi.org/10.1046/j.1365-2249.2000.01365.x.

  23. Musil D. What’s new in the 2020 update of the CEAP classification system of chronic venous disease? Vnitr Lek. Summer. 2021; 67(3): 143–48.

  24. Galsinh H., Singh K., Smith L. Lipodermatosclerosis: The common skin condition often treated as cellulitis. J R Coll Physicians Edinb. 2019; 49(1): 41–42. https://dx.doi.org/10.4997/JRCPE.2019.110.

  25. Alfaro R.A., Davis D.D. Diclofenac. 2021 Jun 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2022 Jan. PMID: 32491802.

  26. da Costa B.R., Pereira T.V., Saadat P. et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: Network meta-analysis. BMJ. 2021; 375: n2321. https://dx.doi.org/10.1136/bmj.n2321.

  27. Wade A.G., Crawford G.M., Young D. et al. Comparison of diclofenac gel, ibuprofen gel, and ibuprofen gel with levomenthol for the topical treatment of pain associated with musculoskeletal injuries. J Int Med Res. 2019; 47(9): 4454–68. https://dx.doi.org/10.1177/0300060519859146.


About the Autors

Olga N. Egorova, MD, leading researcher of the Laboratory of thromboinflammation, V.A. Nasonova Research Institute of Rheumatology. Address: 1115522, Moscow, 34A Kashirskoe Highway. Е-mail: onegorova@yandex.ru. ORCID: https://orcid.org/0000-0002-4846-5531
Galina M. Tarasova, PhD, senior researcher of the Laboratory of thromboinflammation, V.A. Nasonova Research Institute of Rheumatology. Address: 1115522, Moscow, 34A Kashirskoe Highway. Е-mail: verizubgm@gmail.com.
ORCID: https://orcid.org/0000-0001-9933-5350
Alexander M. Lila, MD, professor, Director of V.A. Nasonova Research Institute of Rheumatology. Address: 1115522, Moscow, 34A Kashirskoe Highway. ORCID: https://orcid.org/0000-0002-6068-3080


Similar Articles

Back to Content

Бионика Медиа